Osborn Williams & Donohoe LLC increased its holdings in UnitedHealth Group Inc (NYSE:UNH) by 11.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,551 shares of the healthcare conglomerate’s stock after buying an additional 3,235 shares during the quarter. Osborn Williams & Donohoe LLC’s holdings in UnitedHealth Group were worth $7,943,000 at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of the stock. Eastern Bank boosted its stake in UnitedHealth Group by 2.0% during the 2nd quarter. Eastern Bank now owns 69,088 shares of the healthcare conglomerate’s stock valued at $16,858,000 after purchasing an additional 1,375 shares in the last quarter. Enterprise Bank & Trust Co bought a new position in UnitedHealth Group during the 1st quarter valued at $3,785,000. Private Advisors LLC boosted its stake in UnitedHealth Group by 57.9% during the 1st quarter. Private Advisors LLC now owns 6,501 shares of the healthcare conglomerate’s stock valued at $1,607,000 after purchasing an additional 2,385 shares in the last quarter. First City Capital Management Inc. bought a new position in UnitedHealth Group during the 4th quarter valued at $580,000. Finally, Capital Investment Advisors LLC boosted its stake in UnitedHealth Group by 26.2% during the 2nd quarter. Capital Investment Advisors LLC now owns 6,379 shares of the healthcare conglomerate’s stock valued at $1,556,000 after purchasing an additional 1,323 shares in the last quarter. 85.87% of the stock is owned by institutional investors and hedge funds.
UNH has been the subject of a number of research reports. SunTrust Banks decreased their price target on UnitedHealth Group to $300.00 and set a “buy” rating for the company in a research note on Wednesday, April 17th. They noted that the move was a valuation call. ValuEngine lowered UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Thursday, April 18th. Raymond James increased their price target on UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a research note on Friday, July 19th. UBS Group initiated coverage on UnitedHealth Group in a research note on Tuesday, April 23rd. They set a “neutral” rating and a $238.00 price target for the company. Finally, Oppenheimer set a $312.00 price target on UnitedHealth Group and gave the company a “buy” rating in a research note on Friday, July 19th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and eighteen have issued a buy rating to the stock. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $295.06.
Shares of NYSE:UNH traded down $3.22 on Wednesday, reaching $245.06. 211,570 shares of the company traded hands, compared to its average volume of 3,766,270. UnitedHealth Group Inc has a fifty-two week low of $208.07 and a fifty-two week high of $287.94. The firm has a 50 day simple moving average of $251.75. The stock has a market cap of $237.63 billion, a PE ratio of 19.04, a PEG ratio of 1.33 and a beta of 0.61. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.67 and a quick ratio of 0.73.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, beating analysts’ consensus estimates of $3.46 by $0.14. The company had revenue of $60.60 billion during the quarter, compared to the consensus estimate of $60.59 billion. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The company’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $3.14 EPS. As a group, research analysts forecast that UnitedHealth Group Inc will post 14.82 earnings per share for the current fiscal year.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: What is the significance of a dead cat bounce?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.